Evidence map›Paper›PMID 32295844›Full record

ArticleThe Journal of biological chemistry2020

Caifei Liu, Yingxin Shi, Jie Li, Xuewen Liu, Zhikai Xiahou, Zhongping Tan, Xing Chen, Jing Li

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. The O-GlcNAc dichotomy: when does adaptation become pathological?Clinical science (London, England : 1979) · 2023
    Review
  4. Article
  5. The role of O-GlcNAcylation in development.Development (Cambridge, England) · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Centrosomes: Til O-GlcNAc Do Us Apart.Frontiers in endocrinology · 2020
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Caifei LiuBeijing Key Laboratory of DNA Damage Response and College of Life Sciences, Capital Normal University, Beijing 100048, China.
Yingxin ShiBeijing Key Laboratory of DNA Damage Response and College of Life Sciences, Capital Normal University, Beijing 100048, China.
Jie LiBeijing Key Laboratory of DNA Damage Response and College of Life Sciences, Capital Normal University, Beijing 100048, China.
Xuewen LiuDepartment of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410006, China; Key Laboratory of Translational Radiation Oncology, Hunan 410006, China.
Zhikai XiahouBeijing Key Laboratory of DNA Damage Response and College of Life Sciences, Capital Normal University, Beijing 100048, China.
Zhongping TanInstitute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Xing ChenCollege of Chemistry and Molecular Engineering, Beijing National Laboratory for Molecular Sciences, Peking-Tsinghua Center for Life Sciences, Synthetic and Functional Biomolecules Center, and Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, Peking University, Beijing 100871, China.
Jing LiBeijing Key Laboratory of DNA Damage Response and College of Life Sciences, Capital Normal University, Beijing 100048, China. Electronic address: jing_li@mail.cnu.edu.cn.
Capital Normal University · CNBeijing Normal University · CNCentral South University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of

Indexed as

MitosisCDC2 Protein KinaseCell Cycle ProteinsCell LineCentrosomeGlycosylationHumansMyosin-Light-Chain PhosphatasePolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsCDC2 Protein KinaseCDK1 protein, humanCell Cycle ProteinsMyosin-Light-Chain PhosphatasePolo-Like Kinase 1PPP1R12A protein, humanProtein Serine-Threonine KinasesProto-Oncogene ProteinsCDK1cell cyclecentrosomemitosisMYPT1O-GlcNAcylationO-linked N-acetylglucosamine (O-GlcNAc)PLK1protein phosphorylation

Identifiers

PMID32295844
PMCPMC7247298
OpenAlexW3016277935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.